Edge SB - Search Results

1

DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.

Tao MH, Shields PG, Nie J, Millen A, Ambrosone CB, Edge SB, Krishnan SS, Marian C, Xie B, Winston J, Vito D, Trevisan M, Freudenheim JL. Tao MH, et al. Among authors: edge sb. Breast Cancer Res Treat. 2009 Apr;114(3):559-68. doi: 10.1007/s10549-008-0028-z. Epub 2008 May 8. Breast Cancer Res Treat. 2009. PMID: 18463976 Free PMC article.

2

Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.

Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. Stomper PC, et al. Among authors: edge sb. Radiology. 1995 Nov;197(2):387-95. doi: 10.1148/radiology.197.2.7480682. Radiology. 1995. PMID: 7480682

3

Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage.

Stomper PC, Penetrante RB, Edge SB, Arredondo MA, Blumenson LE, Stewart CC. Stomper PC, et al. Among authors: edge sb. Breast Cancer Res Treat. 1996;37(3):229-36. doi: 10.1007/BF01806504. Breast Cancer Res Treat. 1996. PMID: 8825134

4

Sentinel node biopsy in breast cancer.

Barnwell JM, Arredondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, Zhang P, Winston J, Edge SB. Barnwell JM, et al. Among authors: edge sb. Ann Surg Oncol. 1998 Mar;5(2):126-30. doi: 10.1007/BF02303845. Ann Surg Oncol. 1998. PMID: 9527265

5

Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.

Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Asch HL, et al. Among authors: edge sb. Breast Cancer Res Treat. 1999 May;55(2):179-88. doi: 10.1023/a:1006203632228. Breast Cancer Res Treat. 1999. PMID: 10481945

6

Downregulation of gelsolin correlates with the progression to breast carcinoma.

Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. Winston JS, et al. Among authors: edge sb. Breast Cancer Res Treat. 2001 Jan;65(1):11-21. doi: 10.1023/a:1006446108411. Breast Cancer Res Treat. 2001. PMID: 11245335

7

Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection.

Kane JM 3rd, Edge SB, Winston JS, Watroba N, Hurd TC. Kane JM 3rd, et al. Among authors: edge sb. Ann Surg Oncol. 2001 May;8(4):361-7. doi: 10.1007/s10434-001-0361-5. Ann Surg Oncol. 2001. PMID: 11352311

8

Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma.

Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB. Sabel MS, et al. Among authors: edge sb. J Surg Oncol. 2001 Aug;77(4):243-6. doi: 10.1002/jso.1103. J Surg Oncol. 2001. PMID: 11473372

9

Altered expression and localization of PKC eta in human breast tumors.

Masso-Welch PA, Winston JS, Edge S, Darcy KM, Asch H, Vaughan MM, Ip MM. Masso-Welch PA, et al. Breast Cancer Res Treat. 2001 Aug;68(3):211-23. doi: 10.1023/a:1012265703669. Breast Cancer Res Treat. 2001. PMID: 11727958

10

Breast cancer risk factors and HER2 over-expression in tumors.

Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Swede H, et al. Among authors: edge sb. Cancer Detect Prev. 2001;25(6):511-9. Cancer Detect Prev. 2001. PMID: 12132871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page